Form 4: Mondelez Executive Stevens Receives Equity Grant

Sentiment:

Insider Transaction Report


Mondelez International's SVP, CTR & Chief Accounting Officer, Brian Stevens, was granted 1,970 deferred stock units and 11,820 stock options, vesting over three years.

Summary

  • Brian Stevens, SVP, CTR & Chief Accounting Officer of Mondelez International, Inc. (MDLZ), received an equity grant on February 11, 2026.
  • The grant includes 1,970 deferred stock units (DSUs) under the Issuer's 2024 Performance Incentive Plan.
  • These DSUs will vest in three annual installments: 33% on February 11, 2027, 33% on February 11, 2028, and 34% on February 11, 2029.
  • Additionally, Stevens was granted 11,820 stock options with an exercise price of $61.47 and an expiration date of February 11, 2036.
  • The stock options also vest in three annual installments: 33% on February 11, 2027, 33% on February 11, 2028, and 34% on February 11, 2029.
  • A Power of Attorney, effective April 1, 2025, was executed by Brian Stevens on April 4, 2025, appointing Jamie L. East and Laura Stein to handle his SEC Section 16 filings.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management incentives with long-term company performance and shareholder interests.

Positives

  • The equity grant aligns the executive's interests with long-term shareholder value through performance-based incentives.
  • The vesting schedule encourages executive retention over a multi-year period.

Future Outlook

The equity grants for Brian Stevens are structured with a multi-year vesting schedule, indicating a long-term incentive plan that extends through February 2029 for vesting and February 2036 for stock option expiration.

Industry Context

StockSavvy.ai notes that routine executive equity grants, such as those reported by Mondelez, are a standard practice across the consumer staples industry. These grants are typically designed to align executive incentives with long-term shareholder value creation and promote executive retention, a common strategy employed by peers like PepsiCo and Nestlé to maintain leadership stability and strategic continuity.

Comparison to Industry Standards

  • The use of deferred stock units and stock options with multi-year vesting schedules is a common compensation structure for senior executives in large consumer goods companies, comparable to practices at Unilever or Coca-Cola.
  • The vesting schedule of three annual installments is typical for long-term incentive plans, aiming to retain talent and incentivize sustained performance, aligning with global benchmarks for executive compensation.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantBrian Stevens granted a Power of Attorney to Jamie L. East and Laura Stein to handle his Section 16 filings (Forms 3, 4, and 5) with the SEC.2025-04-01Streamlines the process for executive compliance with SEC reporting requirements, ensuring timely and accurate disclosure of insider transactions.

Stakeholder Impact

  • Shareholders: The equity grant aligns executive interests with shareholder value creation, potentially leading to better long-term performance.
  • Employees: May signal stability in executive leadership and a commitment to performance-based compensation structures.

Next Steps

  • First vesting installment of DSUs and stock options on February 11, 2027.
  • Second vesting installment of DSUs and stock options on February 11, 2028.
  • Third vesting installment of DSUs and stock options on February 11, 2029.
  • Stock options remain exercisable until their expiration on February 11, 2036.

Key Dates

DateDescription
2025-04-01Effective date of the Power of Attorney for SEC filings.
2025-04-04Date Brian Stevens executed the Power of Attorney.
2026-02-11Date of the equity grant transaction for deferred stock units and stock options.
2026-02-13Date the Form 4 was signed by Power of Attorney.
2027-02-11First vesting installment (33%) for deferred stock units and stock options.
2028-02-11Second vesting installment (33%) for deferred stock units and stock options.
2029-02-11Third vesting installment (34%) for deferred stock units and stock options.
2036-02-11Expiration date for the granted stock options.

Recommendation

hold

This Form 4 filing reports a routine equity grant to a senior executive, which is a standard part of compensation and does not provide new information significant enough to alter the fundamental investment thesis for Mondelez International. It reinforces executive alignment with long-term performance but does not indicate a catalyst for immediate price movement.

Keywords

Mondelez International, MDLZ, Brian Stevens, Form 4, SEC Filing, Equity Grant, Stock Options, Deferred Stock Units, Executive Compensation, Insider Transaction, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.